EUVIMEDEUVIMED entdecken
Querschnittstudie

Plasma biomarkers for Alzheimer's disease in middle-aged and older Japanese men: A population-based cross-sectional study

Masaki Nakano iD, Keiko Kondo iD, Kengo Ishiki, Mohammad Moniruzzaman, Yachiyo Mitsuishi, Aya Kadota, Shunsuke Watanabe iD, Kazuto Yamashita, Masahiro Miura iD, Shigeki Iwanaga, Toshiyuki Sato, Masaki Nishimura iD und 1 weitere

Journal of Alzheimer’s Disease · 2026

DOI: 10.1177/13872877251409337 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Masaki Nakano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neuroscience Research Center, Shiga University of Medical Science, Shiga, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, tau Proteins. Die Arbeit nennt 37 Literaturangaben. Gefördert von: the Sysmex Corporation, Japan Society for the Promotion of Science, Agency for Cultural Affairs, Government of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The diagnostic value of blood-based biomarkers for Alzheimer's disease (AD) neuropathology has been demonstrated in individuals with cognitive impairment; however, evidence for reliable preclinical stage diagnostic methods remains insufficient.

Objective

To identify confounding variables that may obscure the interpretation of these biomarkers, we examined their associations with various physiological indices including age, renal function, and cognitive function in Japanese men from the general population.

Methods

Plasma were collected from 845 randomly selected Japanese men participants (aged >40 years) to measure 40- and 42-amino acid amyloid-β (Aβ 40 and Aβ 42 ), total tau (T-tau), tau phosphorylated at threonine 181 (P-tau181), and neurofilament light chain (NfL) using an automated immunoassay system. Cognitive function was assessed using the Cognitive Abilities Screening Instrument (CASI). Linear regression models were constructed to estimate association strengths with correction for possible confounding variables.

Results

Plasma Aβ 40 , Aβ 42 , T-tau, P-tau181, NfL, and P-tau181/T-tau increased with age and declining glomerular filtration rate (eGFR), whereas Aβ 42 /Aβ 40 decreased with age. Higher T-tau and P-tau181 were associated with lower CASI scores after adjusting for age and eGFR. Individuals in older age groups with Aβ 42 /Aβ 40 ratios less than or equal to a cutoff (“amyloid-positive”) also exhibited higher P-tau181, NfL, and P-tau181/T-tau than amyloid-negative individuals, with no significant difference in mean CASI score.

Conclusions

Our results confirm that plasma AD biomarkers are significantly influenced by age and renal clearance rate. Notably, higher T-tau and P-tau181 were associated with preclinical cognitive impairment. Additionally, a lower Aβ 42 /Aβ 40 was associated with asymptomatic tau pathology and neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-Peptidestau ProteinsHumansMaleBiomarkersAgedMiddle AgedCross-Sectional StudiesPeptide FragmentsJapanNeurofilament ProteinsAged, 80 and overAdultEast Asian People

Stichwörter der Autor:innen

Alzheimer's diseaseageamyloid-βblood-based biomarkercognitive impairmentrenal functiontau

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsPeptide FragmentsNeurofilament Proteinsneurofilament protein Lamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Molecular Neuroscience Research Center, Shiga University of Medical Science, Shiga, Japan.
  • NCD Epidemiology Research Center, Shiga University of Medical Science, Shiga, Japan.
  • Central Research Laboratories, Sysmex Corporation, Hyogo, Japan.
  • Department of Neurology, Yoka Municipal Hospital, Hyogo, Japan.
  • Glocal Institute of Medicine, Culture and Economy, Hyogo, Japan.

ORCID-Profile: Masaki Nakano, Keiko Kondo, Shunsuke Watanabe, Masahiro Miura, Masaki Nishimura, Katsuyuki Miura

Förderung

  • the Sysmex Corporation
  • Japan Society for the Promotion of Science
  • Agency for Cultural Affairs, Government of Japan

Zitieren

APA

Nakano, M., Kondo, K., Ishiki, K., Moniruzzaman, M., Mitsuishi, Y., Kadota, A., Watanabe, S., Yamashita, K., Miura, M., Iwanaga, S., Sato, T., Nishimura, M., & Miura, K. (2026). Plasma biomarkers for Alzheimer's disease in middle-aged and older Japanese men: A population-based cross-sectional study. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251409337

Vancouver

Nakano M, Kondo K, Ishiki K, Moniruzzaman M, Mitsuishi Y, Kadota A, et al. Plasma biomarkers for Alzheimer's disease in middle-aged and older Japanese men: A population-based cross-sectional study. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877251409337

BibTeX
@article{Nakano2026,
  author = {Nakano, Masaki and Kondo, Keiko and Ishiki, Kengo and Moniruzzaman, Mohammad and Mitsuishi, Yachiyo and Kadota, Aya and Watanabe, Shunsuke and Yamashita, Kazuto and Miura, Masahiro and Iwanaga, Shigeki and Sato, Toshiyuki and Nishimura, Masaki and Miura, Katsuyuki},
  title = {Plasma biomarkers for Alzheimer's disease in middle-aged and older Japanese men: A population-based cross-sectional study},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877251409337}
}
Kostenlos starten →